Biotech

Alethia Biotherapeutics Closes a $4.7 Million Financing to Advance its Bone Antiresorptive Program

MONTREAL, QUEBEC: ...

Phase III Data Show Greater Compliance Across Demographic Groups With Agile Therapeutics' Contraceptive Patch Compared to an Oral Contraceptive

PRINCETON, NJ: High Patch Compliance Not Affected by Age, Race, or Education ...

Progressive Care Inc. Signs New Service Agreements With Seven South Florida Healthcare Institutions

MIAMI, FL: ...

Corcept Therapeutics Announces Third Quarter Results and Corporate Update

MENLO PARK, CA: ...

MethylGene to Present MGCD265 Data at the 24th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

MONTREAL, CANADA: ...

New Data Support Ability of PS-Targeting Antibodies to Specifically Target Tumors and Stimulate Cancer-Fighting Immune Responses

TUSTIN, CA: Presentation at the 27th Annual Meeting of the Society for Immunotherapy of Cancer Highlights Ability of PS-Targeting Antibodies to Induce Innate and Adaptive Immune Responses; Published Article in Nu ...

Enzon Reports Third Quarter 2012 Results

PISCATAWAY, NJ: ...

Calyx's Operating Subsidiary Makes Aviation History, Powers the World's First 100% Biofuel Flight

VANCOUVER, BRITISH COLUMBIA: ...

Horizon Pharma to Host Conference Call and Webcast to Discuss Third Quarter 2012 Financial Results on November 13, 2012

DEERFIELD, IL: ...

Bio-Matrix Scientific Group, Inc. Announces Participation in the 2012 Stem Cell Meeting on the Mesa's Investor and Partnering Forum

SAN DIEGO, CA: ...